Clinical Trial Update: Metformin and Vascular Function in Prediabetes [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating metformin for vascular function in individuals with prediabetes has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prediabetes

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Diana Jalal | Conditions: PreDiabetes | Phase 2 | Status: WITHDRAWN